Literature DB >> 2079636

Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.

T Sasaki1, M Kishi, M Saito, T Tanaka, N Higuchi, E Kominami, N Katunuma, T Murachi.   

Abstract

Eight different di- and tripeptidyl aldehyde derivatives, each having at its C-terminus an aldehyde analog of L-norleucine, L-methionine, or L-phenylalanine with a preceding L-leucine residue, were synthesized and tested for their inhibitory effects on several serine and cysteine endopeptidases. These compounds showed almost no inhibition of trypsin, and only weak inhibition of alpha-chymotrypsin and cathepsin H, while they exhibited marked inhibition of cathepsin B less than calpain II congruent to calpain I less than cathepsin L, being stronger in this order. The mode of inhibition of these cysteine proteinases was competitive for the peptide substrate used and inhibitor constants (Ki) were calculated from the Dixon plot. The best inhibitors found were: 4-phenyl-butyryl-Leu-Met-H for calpain I (Ki, 36 nM) and calpain II (Ki, 50 nM); acetyl-Leu-Leu-nLeu-H for cathepsin L (Ki, 0.5 nM); acetyl-Leu-Leu-Met-H for cathepsin B (Ki, 100 nM).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079636     DOI: 10.3109/14756369009035837

Source DB:  PubMed          Journal:  J Enzyme Inhib        ISSN: 1026-5457


  47 in total

1.  Targeting proteases in atherosclerosis: hitting the nail with the hammer.

Authors:  Daniel I Simon; Mukesh K Jain
Journal:  Circulation       Date:  2011-12-06       Impact factor: 29.690

2.  In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium.

Authors:  Santhosh K Mani; Hirokazu Shiraishi; Sundaravadivel Balasubramanian; Kentaro Yamane; Meenakshi Chellaiah; George Cooper; Naren Banik; Michael R Zile; Dhandapani Kuppuswamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

3.  An experimental platform for systemic drug delivery to the retina.

Authors:  Matthew Campbell; Anh T H Nguyen; Anna-Sophia Kiang; Lawrence C S Tam; Oliviero L Gobbo; Christian Kerskens; Sorcha Ni Dhubhghaill; Marian M Humphries; G-Jane Farrar; Paul F Kenna; Peter Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

4.  Proteasome inhibitors prevent tracheary element differentiation in zinnia mesophyll cell cultures

Authors: 
Journal:  Plant Physiol       Date:  1998-10       Impact factor: 8.340

5.  Identification and optimization of a novel inhibitor of mitochondrial calpain 10.

Authors:  Kyle A Rasbach; David D Arrington; Sina Odejinmi; Chris Giguere; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

6.  Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors.

Authors:  Suzanne M Underhill; Mark P Goldberg
Journal:  Neurobiol Dis       Date:  2006-10-27       Impact factor: 5.996

7.  Limitations of SLLVY-AMC in calpain and proteasome measurements.

Authors:  Christopher J Giguere; Rick G Schnellmann
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

8.  Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells.

Authors:  Byong Hoon Yoo; Xue Wu; Yongling Li; Mehnaaz Haniff; Takehiko Sasazuki; Senji Shirasawa; Eeva-Liisa Eskelinen; Kirill V Rosen
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

9.  Calpain 4 is not necessary for LFA-1-mediated function in CD4+ T cells.

Authors:  Sarah A Wernimont; William T N Simonson; Peter A Greer; Christine M Seroogy; Anna Huttenlocher
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

10.  Myofibril-inducing RNA (MIR) is essential for tropomyosin expression and myofibrillogenesis in axolotl hearts.

Authors:  Chi Zhang; Pingping Jia; Xupei Huang; Gian Franco Sferrazza; Gagani Athauda; Mohan P Achary; Jikui Wang; Sharon L Lemanski; Dipak K Dube; Larry F Lemanski
Journal:  J Biomed Sci       Date:  2009-09-03       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.